Freeman Kevin D (CIK 0001522478)

Latest company ownership

Shares held
93,063
Last filed at
Jun 20, 2024
Confidence Score
94.0
2025Q4
Confidence Score History
2013Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 23, 2025 Dec 23, 2025 GALECTIN THERAPEUTICS INC Director Buy 83.8 +5,500 3.72% ✗ $19.5K
Dec 23, 2025 Dec 23, 2025 GALECTIN THERAPEUTICS INC Director Buy 83.8 +5,500 4.17% ✗ $19.5K
Dec 23, 2025 Dec 23, 2025 GALECTIN THERAPEUTICS INC Director Buy 83.8 +5,500 4.17% ✗ $19.5K
Jul 17, 2025 Jul 18, 2025 GALECTIN THERAPEUTICS INC Director Buy 83.8 +5,000 3.50% ✗ $14.5K
Dec 24, 2024 Dec 26, 2024 GALECTIN THERAPEUTICS INC Director Buy 85.0 +10,000 7.53% ✗ $8.1K
Oct 17, 2024 Oct 17, 2024 GALECTIN THERAPEUTICS INC Director Buy 67.5 +1,300 0.99% ✗ $3.4K
Oct 16, 2024 Oct 16, 2024 GALECTIN THERAPEUTICS INC Director Buy 86.3 +10,000 8.23% ✗ $27K
Jun 20, 2024 Jun 20, 2024 GALECTIN THERAPEUTICS INC Director Buy 77.5 +2,500 2.10% ✗ $5.9K
Apr 22, 2024 Apr 22, 2024 GALECTIN THERAPEUTICS INC Director Buy 77.5 +2,500 2.15% ✗ $7.5K
Oct 28, 2022 Oct 31, 2022 GALECTIN THERAPEUTICS INC Director Buy 86.3 +10,000 9.57% ✗ $14.1K
May 19, 2022 May 20, 2022 GALECTIN THERAPEUTICS INC Director Buy 85.0 +5,000 5.03% ✗ $6.6K
Apr 18, 2022 Apr 18, 2022 GALECTIN THERAPEUTICS INC Director Buy 85.0 +5,000 5.29% ✗ $8.6K
Jan 19, 2022 Jan 19, 2022 GALECTIN THERAPEUTICS INC Director Buy 85.0 +5,000 5.59% ✗ $9.8K
Jan 19, 2022 Jan 19, 2022 GALECTIN THERAPEUTICS INC Director Buy 85.0 +5,000 5.92% ✗ $9.8K
Dec 15, 2021 Dec 15, 2021 GALECTIN THERAPEUTICS INC Director Buy 86.3 +5,000 5.92% ✗ $11.4K
Dec 6, 2021 Dec 15, 2021 GALECTIN THERAPEUTICS INC Director Buy 86.3 +5,000 5.92% ✗ $11.4K
Dec 6, 2021 Dec 6, 2021 GALECTIN THERAPEUTICS INC Director Buy 86.3 +5,000 6.29% ✗ $11.7K
Oct 29, 2021 Nov 1, 2021 GALECTIN THERAPEUTICS INC Director Buy 82.5 +2,000 2.58% ✗ $6.3K
Oct 21, 2021 Oct 21, 2021 GALECTIN THERAPEUTICS INC Director Buy 82.5 +2,000 2.65% ✗ $6.4K
Oct 19, 2021 Oct 19, 2021 GALECTIN THERAPEUTICS INC Director Buy 83.8 +3,000 4.14% ✗ $10.1K
Sep 23, 2021 Sep 23, 2021 GALECTIN THERAPEUTICS INC Director Buy 83.8 +3,000 4.32% ✗ $11.6K
Apr 5, 2021 Apr 6, 2021 GALECTIN THERAPEUTICS INC Director Buy 86.3 +5,000 7.76% ✗ $10.2K
Sep 4, 2020 Sep 9, 2020 GALECTIN THERAPEUTICS INC Director Buy 86.3 +5,000 8.41% ✗ $12.8K
Mar 19, 2020 Mar 20, 2020 GALECTIN THERAPEUTICS INC Director Buy 90.0 +6,000 11.22% ✗ $9.8K
Nov 15, 2019 Nov 18, 2019 GALECTIN THERAPEUTICS INC Director Buy 86.3 +3,000 5.94% ✗ $10.1K
Sep 6, 2019 Sep 9, 2019 GALECTIN THERAPEUTICS INC Director Buy 82.5 +1,290 2.62% ✗ $4.8K
May 31, 2019 Jun 3, 2019 GALECTIN THERAPEUTICS INC Director Buy 91.3 +9,136 22.82% ✗ $39.1K
Apr 5, 2019 Apr 8, 2019 GALECTIN THERAPEUTICS INC Director Buy 77.5 +500 1.26% ✗ $2.4K
Feb 8, 2019 Feb 11, 2019 GALECTIN THERAPEUTICS INC Director Buy 82.5 +1,500 3.94% ✗ $6.4K
Feb 1, 2018 Feb 2, 2018 GALECTIN THERAPEUTICS INC Director Buy 85.0 +2,000 5.55% ✗ $8.2K
Feb 1, 2018 Feb 2, 2018 GALECTIN THERAPEUTICS INC Director Buy 85.0 +2,000 5.55% ✗ $8.2K
Dec 7, 2017 Dec 8, 2017 GALECTIN THERAPEUTICS INC Director Buy 91.3 +8,400 30.39% ✗ $13.7K
Jun 1, 2015 Jun 2, 2015 GALECTIN THERAPEUTICS INC Director Buy 90.0 +2,083 53.18% ✗ $5.6K
Aug 15, 2014 Aug 18, 2014 GALECTIN THERAPEUTICS INC Director Buy 90.0 +1,000 34.28% ✗ $4.7K
Nov 18, 2013 Nov 19, 2013 GALECTIN THERAPEUTICS INC Director Buy 90.0 +1,000 52.16% ✗ $6.1K
May 28, 2013 May 30, 2013 GALECTIN THERAPEUTICS INC Director Buy 90.0 +1,000 18.18% ✗ $4.2K